Kisspeptin-10 Protocol
Dosing & Research
Last Updated: September 4, 2026
Chemical Identity
- Amino Acid Sequence
- Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2
- Molecular Formula
- C63H83N17O14
- Molecular Weight
- 1302.45 g/mol
- CAS Number
- 374675-21-5
Fertility and ovulation research, GnRH pulse generation, Reproductive endocrinology, Puberty/HPG-axis studies
Half-Life
~28 Minutes
Administration
Subcutaneous
Frequency
1-2 times per week maximum (avoid daily use)
How It Works
- Fertility and ovulation research
- GnRH pulse generation
- Reproductive endocrinology
- Puberty/HPG-axis studies
Dosing Structure
Dose
~100mcg per injection (1 mcg/kg body weight)
Frequency
1-2 times per week maximum (avoid daily use)
Notes
Optimal single dose: 1 mcg/kg body weight (~100 mcg for average adult). Frequency: 1-2 injections per week maximum — daily administration causes receptor desensitization and should be avoided. Female Fertility Specific: per fertility cycle protocol under medical supervision. Inject: Belly, thigh, upper arm. Break: 2-4 weeks between cycles. Monitor LH, FSH, testosterone levels during research.
Example Protocols
Dose: ~100mcg per injection (1 mcg/kg body weight)
Frequency: 1-2 times per week maximum (avoid daily use)
Duration: 4-8 weeks on, 2-4 weeks off
Off Period: Not listed
Find Research Grade Kisspeptin-10
Recommended vendors for sourcing research-grade material. PeptaBase does not sell peptides directly.
Vendor One Research Labs
COA VerifiedThird-party COA-verified research peptides with published batch testing.
Source Coming SoonVendor Two Sciences
Purity TestedUS-based research compound supplier with independent purity testing.
Source Coming SoonVendor Three Peptide Co.
Bulk research peptide sourcing with batch-level documentation.
Source Coming SoonProtocol Notes
•
Optimal single dose: 1 mcg/kg body weight (~100 mcg for average adult).
•
Frequency: 1-2 injections per week maximum — daily administration causes receptor desensitization and should be avoided.
•
Female Fertility Specific: per fertility cycle protocol under medical supervision.
•
Inject: Belly, thigh, upper arm.
•
Break: 2-4 weeks between cycles.
•
Monitor LH, FSH, testosterone levels during research.
Research & Studies
Loading citations…
Research Feedback
0 approved
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Be the first to submit research feedback for this peptide.
Approved submissions will appear here as aggregated insights.